Anti-CCR8 Antibodies Therapeutic Agents Patent Application

Fri, 10 Apr 2026 01:20:46 +0000
Intellectual Property

USPTO published patent application US20260098096A1 for anti-CCR8 antigen binding proteins and fragments for detection and therapy of various conditions, including cancer. The application was filed September 21, 2023, by inventor Remy Michel Robert. CCR8 is a G-protein coupled receptor implicated in tumor immunosuppression.